tradingkey.logo

Turn Therapeutics Ord Shs

TTRX
4.860USD
+0.130+2.75%
Close 01/23, 16:00ETQuotes delayed by 15 min
136.19MMarket Cap
LossP/E TTM

Turn Therapeutics Ord Shs

4.860
+0.130+2.75%

More Details of Company

Turn Therapeutics Ord Shs Info

Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -

Company Executives of Turn Therapeutics Ord Shs

Name
Name/Position
Position
Shareholding
Change
Mr. Arthur F. Golden
Mr. Arthur F. Golden
Independent Director Nominee
Independent Director Nominee
60.60K
+30400.00%
Mr. Zuraiz Chaudhary
Mr. Zuraiz Chaudhary
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
12.50K
+2500.00%
Dr. Kent Kester
Dr. Kent Kester
Independent Director Nominee
Independent Director Nominee
10.00K
+10000.00%
Mr. Bradley Burnam
Mr. Bradley Burnam
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Andrew Gengos
Mr. Andrew Gengos
Independent Director
Independent Director
--
--
Dr. Neilesh Shailesh (Neil) Ghodadra
Dr. Neilesh Shailesh (Neil) Ghodadra
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Arthur F. Golden
Mr. Arthur F. Golden
Independent Director Nominee
Independent Director Nominee
60.60K
+30400.00%
Mr. Zuraiz Chaudhary
Mr. Zuraiz Chaudhary
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
12.50K
+2500.00%
Dr. Kent Kester
Dr. Kent Kester
Independent Director Nominee
Independent Director Nominee
10.00K
+10000.00%
Mr. Bradley Burnam
Mr. Bradley Burnam
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Andrew Gengos
Mr. Andrew Gengos
Independent Director
Independent Director
--
--
Dr. Neilesh Shailesh (Neil) Ghodadra
Dr. Neilesh Shailesh (Neil) Ghodadra
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--

Revenue Breakdown

Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sun, Jan 18
Updated: Sun, Jan 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BEB Holdings LLC
54.39%
YJA Investment Family LP
4.87%
ANC Carlson Family LP
4.87%
Golden (Arthur F)
0.21%
Clear Street LLC
0.18%
Other
35.48%
Shareholders
Shareholders
Proportion
BEB Holdings LLC
54.39%
YJA Investment Family LP
4.87%
ANC Carlson Family LP
4.87%
Golden (Arthur F)
0.21%
Clear Street LLC
0.18%
Other
35.48%
Shareholder Types
Shareholders
Proportion
Corporation
64.13%
Individual Investor
0.28%
Research Firm
0.18%
Investment Advisor
0.18%
Investment Advisor/Hedge Fund
0.06%
Other
35.17%

Institutional Shareholding

Updated: Wed, Jan 21
Updated: Wed, Jan 21
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
2
71.61K
0.06%
--
2025Q4
2
71.61K
0.24%
+54.47K

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
BEB Holdings LLC
16.02M
54.39%
+16.02M
--
Oct 08, 2025
YJA Investment Family LP
1.43M
4.87%
+1.43M
--
Oct 08, 2025
ANC Carlson Family LP
1.43M
4.87%
+1.43M
--
Oct 08, 2025
Golden (Arthur F)
60.60K
0.21%
+30.40K
+100.66%
Nov 24, 2025
Clear Street LLC
54.47K
0.18%
+54.47K
--
Oct 08, 2025
Geode Capital Management, L.L.C.
17.14K
0.06%
--
--
Nov 30, 2025
Chaudhary (Zuraiz)
12.50K
0.04%
+2.50K
+25.00%
Dec 12, 2025
Kester (Kent Edward)
10.00K
0.03%
+10.00K
--
Oct 08, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI